TCF7L1 is a transcription factor that functions as a context-dependent regulator of Wnt signaling. It acts predominantly as a transcriptional repressor, recruiting corepressor complexes including CtBP and HDAC1 to target promoters 1. In the absence of β-catenin, TCF7L1 represses Wnt-responsive genes; β-catenin binding can modulate its activity 1. In development, TCF7L1 maintains pluripotency in human and mouse embryonic stem cells by suppressing primitive streak and primitive endoderm specification genes including NODAL, BMP4, and WNT3 23. TCF7L1 protein levels are regulated by Wnt-β-catenin signaling through Tbl1-mediated ubiquitylation, linking pathway activation to TCF7L1 degradation 4. In colorectal cancer, TCF7L1 functions as an oncogenic repressor. It suppresses the Wnt antagonist DICKKOPF4 and the migration-inhibitor GAS1, promoting cancer cell proliferation and metastatic potential 15. TCF7L1 is also involved in chr2 translocations in colorectal cancer, with NAV2-TCF7L1 fusion identified as a recurrent alteration 6. In liver, TCF7L1 functions as a periportal Wnt inhibitor involved in hepatocyte zonation 78, suggesting tissue-specific roles in metabolic organization.